234 related articles for article (PubMed ID: 14702266)
1. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients.
Janno S; Holi M; Tuisku K; Wahlbeck K
Am J Psychiatry; 2004 Jan; 161(1):160-3. PubMed ID: 14702266
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients.
Parksepp M; Ljubajev Ü; Täht K; Janno S
Nord J Psychiatry; 2016 Oct; 70(7):498-502. PubMed ID: 27093226
[TBL] [Abstract][Full Text] [Related]
3. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
[TBL] [Abstract][Full Text] [Related]
4. Changing epidemiology of tardive dyskinesia: an overview.
Jeste DV; Wyatt RJ
Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of spontaneous dyskinesia in schizophrenia.
Fenton WS
J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns.
Janno S; Holi MM; Tuisku K; Wahlbeck K
BMC Neurol; 2008 Apr; 8():10. PubMed ID: 18419829
[TBL] [Abstract][Full Text] [Related]
7. High exposure to neuroleptics in bipolar patients: a retrospective review.
Brotman MA; Fergus EL; Post RM; Leverich GS
J Clin Psychiatry; 2000 Jan; 61(1):68-72; quiz 73. PubMed ID: 10695653
[TBL] [Abstract][Full Text] [Related]
8. The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels.
McCreadie RG; Robertson LJ; Wiles DH
Br J Psychiatry; 1992 Jun; 160():793-9. PubMed ID: 1352165
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of akathisia in patients receiving stable doses of clozapine.
Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
[TBL] [Abstract][Full Text] [Related]
10. Historical perspective on movement disorders.
Friedman JH
J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
[TBL] [Abstract][Full Text] [Related]
11. Not all that moves is tardive dyskinesia.
Khot V; Wyatt RJ
Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
[TBL] [Abstract][Full Text] [Related]
12. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
Janno S; Holi MM; Tuisku K; Wahlbeck K
Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
Richardson MA; Haugland G; Craig TJ
Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.
Owens DG; Johnstone EC; Frith CD
Arch Gen Psychiatry; 1982 Apr; 39(4):452-61. PubMed ID: 6121546
[TBL] [Abstract][Full Text] [Related]
15. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
Modestin J; Wehrli MV; Stephan PL; Agarwalla P
Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of tardive dyskinesia Part I.
Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Pires P; Villenueve
Dis Nerv Syst; 1976 Apr; 37(4):210-4. PubMed ID: 3394
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of extrapyramidal effects by neuroleptics in admitted people with schizophrenia].
Moreno-Calvete MC
Enferm Clin; 2013; 23(3):114-7. PubMed ID: 23755945
[TBL] [Abstract][Full Text] [Related]
19. Involuntary disorders of movement in chronic schizophrenia--the role of the illness and its treatment.
Owens DG
Psychopharmacology Suppl; 1985; 2():79-87. PubMed ID: 2860663
[TBL] [Abstract][Full Text] [Related]
20. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
Go CL; Rosales RL; Caraos RJ; Fernandez HH
Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
